WEAVER CONSULTING GROUP – Bristol-Myers Squibb Company Transaction History
WEAVER CONSULTING GROUP portfolio value:
$396,000
portfolio value
WEAVER CONSULTING GROUP quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.05% | -3 shares | -33K | $71.09 | 5.57K |
Q2 2022 | share | Decrease | -7.92% | -480 shares | -13K | $77 | 5.57K |
Q1 2022 | share | 0.00% | 0 shares | 64K | $73.03 | 6.05K | |
Q4 2021 | share | Decrease | -5.42% | -347 shares | -1K | $62.52 | 6.05K |
Q3 2021 | share | Increase | +4.30% | 264 shares | -31K | $59.17 | 6.40K |
Q2 2021 | share | Increase | +14.98% | 800 shares | 73K | $65.79 | 6.14K |
Q1 2021 | share | Decrease | -3.63% | -201 shares | -7K | $62.15 | 5.34K |
Q4 2020 | share | Decrease | -3.28% | -188 shares | -1K | $60.6 | 5.54K |
Q3 2020 | share | Decrease | -4.64% | -279 shares | -8K | $58 | 5.72K |
Q2 2020 | share | 0.00% | 0 shares | 18K | $56.14 | 6.00K | |
Q1 2020 | share | Increase | +1.73% | 102 shares | 35K | $52.79 | 6.00K |
Q4 2019 | share | 0.00% | 0 shares | 37K | $60.36 | 5.90K | |
Q3 2019 | share | Increase | +3.51% | 200 shares | 4K | $47.3 | 5.90K |
Q2 2019 | share | 0.00% | 0 shares | -4K | $41.93 | 5.70K | |
Q1 2019 | share | Increase | 0.00% | 5.70K shares | 263K | $43.73 | 5.70K |